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Abstract
OBJECTIVE—The objective of the study was to examine the associations between prenatal and 
postpartum contraceptive counseling and postpartum contraceptive use.
STUDY DESIGN—The Pregnancy Risk Assessment Monitoring System 2004–2008 data were 
analyzed from Missouri, New York state, and New York City (n = 9536). We used multivariable 
logistic regression to assess the associations between prenatal and postpartum contraceptive 
counseling and postpartum contraceptive use, defined as any method and more effective methods 
(sterilization, intrauterine device, or hormonal methods).
RESULTS—The majority of women received prenatal (78%) and postpartum (86%) 
contraceptive counseling; 72% received both. Compared with those who received no counseling, 
those counseled during 1 time period (adjusted odds ratio [AOR], 2.10; 95% confidence interval 
[CI], 1.65–2.67) and both time periods (AOR, 2.33; 95% CI, 1.87–2.89) had significantly 
increased odds of postpartum use of a more effective contraceptive method (32% vs 49% and 
56%, respectively; P for trend < .0001). Results for counseling during both time periods differed 
by type of health insurance before pregnancy, with greater odds of postpartum use of a more 
effective method observed for women with no insurance (AOR, 3.51; 95% CI, 2.18–5.66) and 
Medicaid insurance (AOR, 3.74; 95% CI, 1.98–7.06) than for those with private insurance (AOR, 
1.87; 95% CI, 1.44–2.43) before pregnancy. Findings were similar for postpartum use of any 
contraceptive method, except that no differences by insurance status were detected.
CONCLUSION—The prevalence of postpartum contraceptive use, including the use of more 
effective methods, was highest when contraceptive counseling was provided during both prenatal 
and postpartum time periods. Women with Medicaid or no health insurance before pregnancy 
benefited the most.
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Nearly half of US pregnancies are unintended (UIP), 1 and approximately one-third are 
conceived within 18 months of a previous live birth.2 UIPs have been associated with 
maternal substance use during pregnancy, delayed prenatal care, low birthweight, and 
preterm delivery.3 Short interpregnancy intervals (IPIs) have been associated with small for 
gestational age, low birthweight, and preterm delivery.4
Postpartum contraceptive use is a primary strategy for reducing UIPs and optimizing birth 
spacing5 yet during 2004-2006, 12% of women with a recent live birth reported not using 
any method of contraception and only 62% reported using highly effective methods (ie, 
sterilization, intrauterine device, pills, patch, ring, or shots).6 Less than optimal postpartum 
contraceptive use highlights the need to understand associated factors, including the 
potential role of contraceptive counseling during the prenatal and postpartum periods.
The American College of Obstetricians and Gynecologists and the American Academy of 
Pediatrics recommend that discussion of contraceptive options and prompt initiation of a 
method postpartum should be a primary focus of routine prenatal and postpartum care.7 
Ideally, contraceptive counseling for pregnant women begins during the prenatal period 
because women in the immediate postpartum period are typically focused on childbirth 
recovery and newborn care. Contraceptive counseling during the prenatal and postpartum 
periods is also important because pregnancy and childbirth may change a woman’s 
preference for contraception. In one study, 46% of postpartum women chose to use a 
different method postpartum than the one used before pregnancy, preferring a method that 
was easy to use, had long-term protection, and did not require a monthly pharmacy trip.8
Although studies have reported the effects of prenatal contraceptive counseling on 
postpartum contraceptive use among women9-11 and adolescents,12 the effects of postpartum 
contraceptive counseling, independently and in combination with prenatal contraceptive 
counseling, have not been explored. This analysis examines the associations between 
prenatal contraceptive counseling, postpartum contraceptive counseling, and both prenatal 
and postpartum contraceptive counseling with the use of any and more effective 
contraceptive methods.
Materials and Methods
The Pregnancy Risk Assessment Monitoring System (PRAMS) is an ongoing, population-
based surveillance system that gathers information on maternal behaviors and experiences 
before, during, and after pregnancy from selected states in the United States and New York 
City. Samples of women with recent live births are drawn from state birth certificates 2-6 
months after delivery.
Data are collected by mailed questionnaires; nonrespondents are contacted by telephone. 
The PRAMS questionnaire in each reporting area includes core questions that appear on all 
PRAMS surveys and area-specific questions of interest. To produce data representative of 
the state birth population, data are weighted for sample design, nonresponse, and 
noncoverage. More detail on the PRAMS methodology has been published previously13 and 
is also available from the PRAMS web site (http://www.cdc.gov/prams).
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We analyzed 2004-2008 data from 3 reporting areas (Missouri, New York state [excluding 
New York City], and New York City), the only PRAMS reporting areas that added 
questions on receipt of postpartum contraceptive counseling and specific contraceptive 
methods used postpartum to their core PRAMS surveys. Other PRAMS participating states 
did not collect this information.
To be included in the analyses, reporting areas must have achieved an overall weighted 
response rate of 65% or more for each year of data. Data were included for 2004-2008 for 
New York State, 2004-2007 for New York City, and 2007 for Missouri. The annual 
weighted response rates for these reporting areas during 2004–2008 ranged from 65% to 
73%. The PRAMS project was approved by the Institutional Review Board of the Centers 
for Disease Control and Prevention.
Prenatal contraceptive counseling was measured by asking, “During any of your prenatal 
care visits, did a doctor, nurse, or other health care worker talk with you about any of the 
things listed below? Please count only discussions, not reading materials or videos.” One 
topic listed was birth control methods to use after my pregnancy.
Postpartum contraceptive counseling was measured by asking, “After your new baby was 
born, did a doctor, nurse, or other health care worker talk with you about using birth 
control?” To examine postpartum contraceptive use, women were asked, “Are you or your 
husband or partner doing anything now to keep you from getting pregnant?” and “What kind 
of birth control are you or your husband or partner using now to keep from getting 
pregnant?”
Respondents who answered no to the first question were classified as using no method and 
were not asked the second question, which included 13 response options for specific 
contraceptive methods and other. Respondents answering other were given the opportunity 
to write in a response; some responses were recoded into existing method options or new 
response options that were added (ie, implant, spermicide). PRAMS questions are 
cognitively and field tested prior to being included on the survey and evaluated every 3-4 
years afterward.
More effective methods were defined as those with less than 10% of women experiencing an 
UIP within the first year of typical use based on published effectiveness rates14 and included 
tubal ligation, vasectomy, implant, intrauterine device, shot, pill, patch, or ring; this 
classification was chosen to be consistent with a prior report.6
Less effective methods were those with 10% or more of women experiencing an UIP within 
the first year of typical use and included diaphragm, condoms, cervical cap, sponge, 
withdrawal, spermicide, or rhythm method. Women reporting the use of more than 1 method 
were classified as using the most effective of the multiple methods consistent with prior 
reports.6,10,12
To focus on postpartum women at risk for UIP or short IPI, we excluded women who 
reported that they were currently pregnant (n = 70), were not sexually active at the time of 
the survey (n = 675), or had undergone a hysterectomy (n = 7). We also excluded 
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respondents who answered yes to the postpartum contraceptive use core question and either 
did not respond to the question about the type of contraceptive method used (n = 418) or 
responded other to the question but the write-in response could not be recoded (n= 24).
We excluded women with missing data on the outcome or exposure variables of interest (n = 
431) and women who did not receive prenatal care (n = 108) because these women did not 
have the opportunity to receive prenatal contraceptive counseling. Theoretically, all 
postpartum women had the opportunity to receive postpartum contraceptive counseling (eg, 
in the hospital prior to discharge), so we did not make exclusions based on the receipt of a 
postpartum care visit.
Separate multivariable logistic regression models were used to examine associations 
between prenatal, postpartum, and prenatal and postpartum contraceptive counseling and the 
use of any contraceptive method (yes vs no) and the use of a more effective contraceptive 
method (yes vs a less effective or no method). Based on a priori considerations, we adjusted 
for age group, race/ethnicity, marital status, education, type of insurance before pregnancy, 
pregnancy intention of the most recent live birth, number of previous live births, current 
breast-feeding, months since delivery, reporting area, and year.
To maximize the number of observations included in multivariable analyses, control 
variables with more than 2% missing data were recoded to include missing as a response 
category. We also adjusted for postpartum contraceptive counseling (when examining the 
effect of prenatal contraceptive counseling) and prenatal contraceptive counseling (when 
examining the effect of postpartum contraceptive counseling).
We examined variance inflation factors to rule out potential multicollinearity between our 
covariates. Because we suspected that women who received postpartum sterilization may 
have reported not receiving postpartum contraceptive counseling (eg, they received all 
counseling during pregnancy), we conducted a sensitivity analysis excluding these women 
(n = 863). In this subanalysis, we also examined the association between contraceptive 
counseling and use of long-acting reversible contraceptives (LARCs) classified as a 
polytomous outcome (LARC use and shot, pill, patch, or ring vs a less effective or no 
method).
Among the entire sample, we also examined whether the associations between receiving 
prenatal and postpartum contraceptive counseling and each outcome were modified by 
pregnancy intention or type of health insurance before pregnancy by testing interaction 
terms added to full models. We examined effect modification by type of health insurance 
before rather than during pregnancy because it is a better measure of usual insurance status 
because most US women have access to insurance during pregnancy.15 Where significant (P 
< .05) effect modification was detected, stratum-specific estimates were calculated using 
contrast statements in a single model of the entire analytical sample. All analyses were 
performed on weighted data using SAS-callable SUDAAN (SAS Institute Inc., Cary, NC) to 
account for the complex survey design of the PRAMS.
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Among 11,306 women with a recent live birth in the 3 reporting areas, 10,520 (93%) were 
considered at risk for UIP or short IPI. Among those, 9536 (91%) were eligible for the 
current analysis. The majority (>50%) were aged 25-34 years, non-Hispanic white, married, 
and high school graduates; had private health insurance before pregnancy and at least 1 
previous live birth; reported their most recent pregnancy was intended; had a postpartum 
check-up; were not currently breast-feeding; and were 4–12 months’ postpartum at the time 
of the survey (Table 1).
Related to contraceptive counseling, 78% received prenatal counseling, 86% received 
postpartum counseling, and 72% received both (Table 1). Most women (85%) reported 
using some method of contraception postpartum, with 53% using a more effective method 
(pills were most commonly reported) and 32% using a less effective method (condoms were 
most commonly reported).
Prenatal contraceptive counseling was significantly associated with using any vs no 
contraceptive method postpartum (87% vs 76% among those who did and did not receive 
prenatal counseling; adjusted odds ratio [AOR], 1.53; 95% confidence interval [CI], 1.29–
1.82), and using a more vs less effective or no method postpartum (56% vs 39% among 
those who did and did not receive prenatal counseling; AOR, 1.51; 95% CI, 1.30–1.75) 
(Table 2).
Additionally, postpartum contraceptive counseling was significantly associated with using 
any vs no method postpartum (86% vs 75% among those who did or did not receive 
postpartum counseling; AOR, 1.64; 95% CI, 1.34–2.00) but was not associated with using a 
more vs less effective or no method postpartum (AOR, 1.19; 95% CI, 1.00–1.41). Compared 
with those who received no counseling, those who received counseling during one time 
period (either prenatal or postpartum), and those who received counseling during both time 
periods (prenatal and postpartum) had 2.01 (95% CI, 1.55– 2.59) and 2.74 (95% CI, 2.18–
3.45) increased odds, respectively, of using any method postpartum (69% vs 81% and 87%, 
respectively) and 2.10 (95% CI, 1.65–2.67) and 2.33 (95% CI, 1.87–2.89) increased odds, 
respectively, of using a more effective method postpartum (32% vs 49% and 56%, 
respectively).
Findings from the sensitivity analysis, which excluded women who reported sterilization 
postpartum, found similar results as the main analysis. In general, point estimates were 
similar, except for greater magnitude of association between postpartum contraceptive 
counseling and use of any method and use of a more effective method postpartum, the latter 
of which was also statistically significant (data not shown).
Additionally, a more pronounced incremental increase in odds of postpartum use of a more 
effective contraceptive method was observed comparing women who received no 
counseling (the referent), those who received counseling during 1 time period (AOR, 2.35; 
95% CI, 1.78–3.10), and those who received counseling during both time periods (AOR, 
3.26; 95% CI, 2.54–4.17). When the referent group was changed to those who received 
counseling during 1 time period, those who received counseling during both time periods 
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continued to have significantly increased odds of postpartum use of a more effective 
contraceptive method (AOR, 1.39; 95% CI, 1.19–1.62).
When examining our polytomous outcome variable to assess the effect of counseling efforts 
on LARC uptake, women who received counseling during both time periods (vs no 
counseling) had significantly increased odds of LARC use vs a less effective or no method 
(AOR, 4.25; 95% CI, 2.32–7.77); these women also had significantly increased odds of 
using a non-LARC hormonal method (ie, shot, pill, patch, or ring) vs a less effective or no 
method (AOR, 3.13; 95% CI, 2.42–4.05). Women who received counseling during 1 time 
period (vs no counseling) also had significantly increased odds of LARC use vs a less 
effective or no method (AOR, 2.52; 95% CI, 1.30–4.89) as well as significantly increased 
odds of using a non-LARC hormonal method vs a less effective or no method (AOR, 2.33; 
95% CI, 1.75–3.10).
Among the entire sample, results for counseling during both time periods significantly 
differed by type of health insurance before pregnancy for use of a more effective 
contraceptive method postpartum; the interaction terms between counseling during both 
periods and pregnancy intention were not statistically significant for either outcome. 
Although contraceptive counseling during both time periods (vs no counseling) was 
significant for women in each category of prepregnancy insurance, greater odds of using a 
more effective method postpartum were observed for women with no insurance (AOR, 3.51; 
95% CI, 2.18–5.66) and Medicaid insurance (AOR, 3.74; 95% CI, 1.98–7.06) than for those 
with private insurance (AOR, 1.87; 95% CI, 1.44–2.43) before pregnancy (Table 3). Similar 
findings were observed for contraceptive counseling during 1 time period (prenatal or 
postpartum only).
Among the 15% of women who reported using no method of contraception postpartum to 
prevent pregnancy (n = 1476), 40% stated that they did not want to use birth control, 25% 
reported that they wanted to get pregnant, and 17% reported that their husband or partner did 
not want to use anything (data not shown).
Comment
Only half of the postpartum women at risk for UIP or short IPI reported using a highly 
effective contraceptive method, highlighting the potential role of contraceptive counseling to 
increase postpartum use and thereby help prevent adverse outcomes associated with UIPs 
and short IPIs. Our findings suggest that prenatal and postpartum contraceptive counseling, 
independently, were associated with postpartum contraceptive use, but the prevalence of 
postpartum contraceptive use, including the use of more effective methods, was highest 
when contraceptive counseling was provided during both prenatal and postpartum periods.
Discussing postpartum contraception prenatally lays the groundwork for decisions about 
postpartum contraception and enables the possibility of initiation in the immediate 
postpartum period, which may be particularly advantageous for women unlikely to return for 
a postpartum care visit. But counseling during the postpartum period is useful to encourage 
contraceptive use among those who have yet to initiate a method, discuss any concerns, and 
reiterate messages on the importance of correct and continued use.
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The greatest benefit of receiving counseling during both time periods was observed for 
women with Medicaid or no insurance before pregnancy compared with those privately 
insured. This may be because underinsured individuals, in general, access health care 
services less frequently16 and thus may gain the most when receiving preventive health 
counseling. It may also be related to the limitations of pregnancy-related Medicaid coverage, 
which is lost 60 days after delivery unless states have Medicaid family-planning eligibility 
expansions extending coverage.17 Other studies have found that postpartum women with 
nonprivate health insurance during pregnancy have a greater likelihood of using effective 
contraceptives postpartum including female sterilization and intrauterine devices18,19 and 
have suggested that underinsured women choose methods that do not require regular contact 
with the health care system, given their inconsistent contraceptive coverage.18 Provider and 
patient preferences may also play a role.
Similar to our findings, state-specific analyses of Florida and New Mexico PRAMS data 
found positive associations between prenatal contraceptive counseling and use of 
contraception postpartum.9,10 Other analyses have found increased postpartum contraceptive 
use among women who received a postpartum care visit,9,12 likely because the visit allows 
women and providers to discuss family planning and providers to initiate or prescribe 
contraceptives. However, not all women attending postpartum care visits receive 
contraceptive counseling. In our sample, 12% of women attending a postpartum care visit 
reported not discussing birth control with a doctor, nurse, or other health care worker after 
the birth of their new baby.
Results from our analysis showed that prenatal and postpartum contraceptive counseling 
increased the use of any and more effective methods. However, even among women who 
reported receiving no counseling, 69% reported some postpartum contraceptive use, but only 
32% reported using more effective methods. Although many of the most effective methods 
require little ongoing effort to use correctly and continuously, they do require provider 
initiation.
Provider counseling and method initiation before hospital discharge may be a practical 
strategy to increase postpartum use of effective contraceptives because women are already 
within the health care system and may not return for follow-up postpartum care visits.7 Also, 
because the majority of the postpartum women in our sample reported the use of pills or 
condoms, counseling on LARCs including intra-uterine devices and implants may increase 
their use. One study found postpartum LARC use to be highest among the women who 
attended more prenatal care visits,20 possibly because of greater opportunity to discuss 
options.
Counseling strategies may consider past and future pregnancy intentions. In our sample, 1 of 
4 women not using contraception reported wanting to get pregnant. These women would 
benefit from counseling on the potential risks of short IPIs.4,21-23 Also, evidence suggests 
that women with a prior UIP or not desiring pregnancy within 2 years have increased 
interest in LARC methods.1,24,25
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We considered several limitations. First, we did not have detailed information about the 
contraceptive counseling received such as content, depth, time spent, where it occurred (eg, 
delivery hospitalization, postpartum outpatient care visit), or number of times women were 
counseled. Second, because PRAMS data are self-reported by women up to 12 months after 
delivery, responses might be subject to social desirability or recall bias. Third, because of 
survey skip patterns, information was not obtained about contraceptive methods used by 
women who might have incorrectly reported that they were not doing anything currently to 
keep from getting pregnant. If this occurred, particularly among respondents who had a tubal 
ligation or whose partner had a vasectomy, the use of effective contraceptive methods might 
have been underestimated. Additionally, the survey did not ascertain the use of the 
lactational amenorrhea method, and we could not estimate the lactational amenorrhea 
method use, given the limited breast-feeding information collected by PRAMS.
Lastly, even though the analysis was conducted using a large population-based sample, we 
were able to report the findings from only 3 reporting areas, limiting the generalizability of 
the findings. Although the prevalence of UIP in our sample of women with a recent live 
birth was lower (35%) than the national average (49%),1 national estimates account for UIPs 
ending in births, abortions, and fetal losses1,25; the UIP in our sample was similar to other 
PRAMS estimates.11 Despite these limitations, our analysis contributes to the literature by 
specifically examining contraceptive counseling during both the prenatal and postpartum 
periods.
Providing contraceptive counseling during prenatal and postpartum periods can be important 
in increasing postpartum contraceptive use, thereby reducing UIP and short IPIs. 
Institutionalizing documentation of contraceptive counseling at prenatal and postpartum 
medical visits through protocols and staff training may ensure that women receive 
counseling during medical visits.
Several promising approaches for providing quality contraceptive counseling have been 
identified and can be incorporated into practice; these include emphasizing the quality of the 
interaction between provider and client, personalizing discussions to meet clients’ individual 
needs, addressing psychosocial determinants of contraceptive use behavior, setting goals and 
developing action plans to deal with anticipated difficulties, and multiple client 
contacts.26,27
Although counseling should include consideration of the full range of postpartum 
contraceptive options that are medically appropriate, providers are encouraged to counsel 
using a tiered approach (ie, presenting information on the most effective methods before 
presenting information on less effective methods).27 According to the Centers for Disease 
Control and Prevention’s US Medical Eligibility Criteria for Contraceptive Use (2010),28,29 
most contraceptive options are considered safe during the postpartum period including many 
effective methods.
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TABLE 1
Sample characteristics, contraceptive counseling, and postpartum contraceptive use, PRAMS, 3 reporting 





 ≤24 2535 27.4
 25-34 5111 54.1
 ≥35 1890 18.5
Race/ethnicity
 Non-Hispanic white 5333 58.1
 Non-Hispanic black 1576 14.2
 Hispanic 1924 20.9
 Non-Hispanic other 697 7.0
Marital status
 Married 5988 62.7
 Other 3547 37.3
Education, y
 <12 1483 17.4
 12 2535 26.7
 >12 5457 55.9
Type of insurance before pregnancy
 None 2233 23.5
 Medicaid (no private) 1066 12.1
Private 6213 64.4
Previous live birth
 0 4218 42.5
 1 2911 31.9
 ≥2 2340 25.5
Pregnancy intention
 Unintended 3271 35.1
 Intended 6118 64.9
Postpartum check-up
 No 754 7.7
 Yes 8766 92.3
Currently breast-feeding
 No 5627 56.8
 Yes 3531 40.7
Missing information 378 2.5

















Time since delivery, mos
 1-3 1130 11.7
 4 4423 45.9
 5-6 2986 31.4
 7-12 760 8.5
 Missing information 237 2.4
Reporting area
 Missouri 1219 8.0
 New York (excluding New York City) 4440 55.2
 New York City 3877 36.7
Reporting year
 2004 1569 18.0
 2005 1864 20.0
 2006 1719 17.8
 2007 3401 32.2
 2008 983 12.1
Prenatal contraceptive counseling
 No 2262 21.8
 Yes 7274 78.2
Postpartum contraceptive counseling
 No 1396 13.9
 Yes 8140 86.1
Prenatal and postpartum counseling
 None 787 7.8
 One (prenatal or postpartum only) 2084 20.2
 Both (prenatal and postpartum) 6665 72.1
Postpartum contraceptive use
 No method 1476 15.4
 More effective method 5028 52.6
  Female sterilization 863 8.6
  Male sterilization 207 2.2
  Intrauterine device 6.3
  Implant 15 0.2
  Pills 2247 24.1
  Patch 212 2.1
  Ring 159 1.5
  Shots 699 7.5
Less effective method 3032 32.0

















 Condoms 2269 23.5
 Diaphragm/cervical cap/sponge 32 0.4
 Withdrawal 434 4.8
 Rhythm or natural family planning 273 3.0
 Spermicides 24 0.3
PRAMS, pregnancy risk assessment monitoring system.
a
Missouri, New York City, and New York;
b
Unweighted n, weighted percentage.
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TABLE 2
Associations between contraceptive counseling and postpartum contraceptive use, PRAMS, 3 reporting areas, 
2004-2008 (n = 9536)a
Contraceptive counseling
Postpartum contraceptive use
Use of any contraceptive method (vs no 
method)
Use of a more effectiveb contraceptive method (vs 
less effectivec or no method)
n (%)d AOR (95% CI)e n (%)d AOR (95% CI)e
Prenatal
 No 1740 (76.4) 1.00 918 (39.2) 1.00
 Yes 6320 (86.9) 1.53 (1.29–1.82)f 4110 (56.4) 1.51 (1.30–1.75)f
Postpartum
 No 1057 (74.8) 1.00 643 (44.6) 1.00
 Yes 7003 (86.2) 1.64 (1.34–2.00)f 4385 (53.9) 1.19 (1.00–1.41)
Prenatal and postpartum
 None 546 (68.5) 1.00 264 (31.8) 1.00
 One (prenatal or postpartum only) 1705 (81.4) 2.01 (1.55–2.59)f 1033 (48.6) 2.10 (1.65–2.67)f
 Both (prenatal and postpartum) 5809 (87.2) 2.74 (2.18–3.45)f 3731 (56.0) 2.33 (1.87–2.89)f
 P for trend <.0001 <.0001
AOR, adjusted odds ratio; CI, confidence interval; PRAMS, pregnancy risk assessment monitoring system.
a
Missouri, New York City, and New York;
b
Includes female sterilization, male sterilization, intrauterine device, implant, pills, patch, ring, or shots;
c
Includes condoms, diaphragm, cervical cap, sponge, withdrawal, rhythm method, or natural family planning;
d
Unweighted n, weighted percentage;
e
Adjusted for maternal age, race/ethnicity, marital status, education, type of insurance before pregnancy, pregnancy intention of most recent live 
birth, number of previous live births, currently breast-feeding, time since pregnancy (months), reporting area, year, receipt of postpartum 
contraceptive counseling (for prenatal contraceptive counseling), and receipt of prenatal contraceptive counseling (for postpartum contraceptive 
counseling);
f
Statistically significant at P < .05.
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TABLE 3
Associations between contraceptive counseling and postpartum contraceptive use, stratified by insurance 
status before pregnancy,a PRAMS, 3 reporting areas,b 2004–2008 (n = 9536)
Prenatal and postpartum contraceptive counseling
Use of a more effectivec contraceptive method (vs less effectived or no method)
n (%)e AOR (95% CI)f
No insurance before pregnancy
 None 58 (28.3) 1.0
 One (prenatal or postpartum only) 242 (54.5) 3.02 (1.76–5.16)g
 Both (prenatal and postpartum) 1000 (61.1) 3.51 (2.18–5.66)g
 P for trend <.0001
Medicaid (no private) insurance before pregnancy
 None 28 (26.9) 1.0
 One (prenatal or postpartum only) 119 (48.1) 2.44 (1.22–4.88)g
 Both (prenatal and postpartum) 486 (66.7) 3.74 (1.98–7.06)g
 P for trend < .0001
Private insurance before pregnancy
 None 178 (34.1) 1.00
 One (prenatal or postpartum only) 669 (46.8) 1.81 (1.36–2.42)g
 Both (prenatal and postpartum) 2239 (52.1) 1.87 (1.44–2.43)g
 P for trend < .0001
AOR, adjusted odds ratio; CI, confidence interval; PRAMS, pregnancy risk assessment monitoring system.
a
Interaction term between contraceptive counseling during both time periods (prenatal and postpartum) and use of a more effective contraceptive 
method was statistically significant at P < .05;
b
Missouri, New York City, and New York;
c
Includes female sterilization, male sterilization, intrauterine device, implant, pills, patch, ring, or shots;
d
Includes condoms, diaphragm, cervical cap, sponge, withdrawal, rhythm method, or natural family planning;
e
Unweighted n, weighted percentage;
f
Adjusted for maternal age, race/ethnicity, marital status, education, type of insurance before pregnancy, pregnancy intention of most recent live 
birth, number of previous live births, currently breast-feeding, time since pregnancy (months), reporting area, and year;
g
Statistically significant at P < .05.
Am J Obstet Gynecol. Author manuscript; available in PMC 2016 February 01.
